Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a potential therapeutic agent for the human subjects with a broad variety of intestinal diseases characterized by intestinal damage and insufficiency.

N-乙酰甘露糖胺是一种单糖，用作糖脂和糖蛋白中神经氨酸的化学或酶合成前体。

10Z-十九碳烯酸是一种具有抗肿瘤活性的长链脂肪酸。